Variation in complications and mortality following ALPPS at early-adopting centers

HPB (Oxford). 2021 Jan;23(1):46-55. doi: 10.1016/j.hpb.2020.04.009. Epub 2020 May 23.

Abstract

Background: Various, often conflicting, estimates for post-operative morbidity and mortality following ALPPS have been reported in the literature, suggesting that considerable center-level variation exists. Some of this variation may be related to center volume and experience.

Methods: Using data from seventeen centers who were early adopters of the ALPPS technique, we estimated the variation, by center, in standardized 90-day mortality and comprehensive complication index (CCI) for patients treated between 2012 and 2018.

Results: We estimated that center-specific 90-day mortality following treatment with ALPPS varied from 4.2% (95% CI: 0.8, 9.9) to 29.1% (95% CI: 13.9, 50.9), and that center-specific CCI following treatment with ALPPS varied from 17.0 (95% CI: 7.5, 26.5) to 49.8 (95% CI: 38.1, 61.8). Declines in estimated 90-day mortality and CCI were observed over time, and almost all individual centers followed this trend. Patients treated at centers with a higher number of ALPPS cases performed over the prior year had a lower risk of post-operative mortality.

Conclusion: Despite considerable center-level variation in ALPPS outcomes, perioperative outcomes following ALPPS have improved over time and treatment at higher volume centers results in a lower risk of 90-day mortality. Morbidity and mortality remain concerningly high at some centers.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Hepatectomy* / adverse effects
  • Humans
  • Ligation
  • Liver Neoplasms* / surgery
  • Portal Vein / diagnostic imaging
  • Portal Vein / surgery
  • Postoperative Complications / etiology
  • Registries
  • Treatment Outcome